PureTech and its Founded Entities collaborate with an extensive network of scientists, clinicians and industry leaders, which has enabled us to consistently gain early access to discoveries well before the rest of the world reads about them and resulting in contributions to over 30 publications in top-tier science journals.
PureTech and its Founded Entities collaborate with an extensive network of scientists, clinicians and industry leaders, which has enabled us to consistently gain early access to discoveries well before the rest of the world reads about them and resulting in contributions to over 30 publications in top-tier science journals.
Bill Bradford
Former SVP InterMune; developed pirfenidone for the treatment of IPF
Bill Bradford
Former SVP InterMune; developed pirfenidone for the treatment of IPF
Vincent Cottin
Professor at Université Claude Bernard Lyon; Coordinator of Center for Rare Pulmonary Diseases at Louis Pradel Hospital; Section Editor of the European Respiratory Journal
Vincent Cottin
Professor at Université Claude Bernard Lyon; Coordinator of Center for Rare Pulmonary Diseases at Louis Pradel Hospital; Section Editor of the European Respiratory Journal
Kevin Flaherty
Professor at University of Michigan; PhIII trial of nintedanib in pfILD (NEJM)
Kevin Flaherty
Professor at University of Michigan; PhIII trial of nintedanib in pfILD (NEJM)
Toby Maher
Professor & Director of ILD at Keck School of Medicine, USC; PhII trial of pirfenidone in uILDs (Lancet RM)
Toby Maher
Professor & Director of ILD at Keck School of Medicine, USC; PhII trial of pirfenidone in uILDs (Lancet RM)
Paul Noble
Chair, Department of Medicine, Cedars-Sinai; results of two late-stage studies evaluating the effect of pirfenidone in patients w/ IPF (Lancet)
Paul Noble
Chair, Department of Medicine, Cedars-Sinai; results of two late-stage studies evaluating the effect of pirfenidone in patients w/ IPF (Lancet)
Marlies Wijsenbeek
Chair of Erasmus Medical Center ILD program; PI on study to identify disease progression in patients with newly diagnosed pfILDs
Marlies Wijsenbeek
Chair of Erasmus Medical Center ILD program; PI on study to identify disease progression in patients with newly diagnosed pfILDs
Michael A. Rogawski, Ph.D., M.D.
Professor of neurology and pharmacology at the University of California Davis
Michael A. Rogawski, Ph.D., M.D.
Professor of neurology and pharmacology at the University of California Davis
Caroline Apovian, MD
Director of the Nutrition and Weight Management Center at Boston Medical Center
Caroline Apovian, MD
Director of the Nutrition and Weight Management Center at Boston Medical Center
Louis J. Aronne, MD, FACP
Sanford I. Weill Professor of Metabolic Research at Weill-Cornell Medical College; Director of the Comprehensive Weight Control Center
Louis J. Aronne, MD, FACP
Sanford I. Weill Professor of Metabolic Research at Weill-Cornell Medical College; Director of the Comprehensive Weight Control Center
Arne Astrup, MD
Head of the Department of Human Nutrition at the University of Copenhagen; Associate Editor of American Journal of Clinical Nutrition
Arne Astrup, MD
Head of the Department of Human Nutrition at the University of Copenhagen; Associate Editor of American Journal of Clinical Nutrition
Alan Breier, PhD
Chief of the Psychotic Disorders Program at Indiana University School of Medicine; former Chief Medical Officer at Eli Lilly
Alan Breier, PhD
Chief of the Psychotic Disorders Program at Indiana University School of Medicine; former Chief Medical Officer at Eli Lilly
David Elmaleh, PhD
Director of Contrast Media Chemistry at the Massachusetts General Hospital; Associate Professor at Harvard Medical School
David Elmaleh, PhD
Director of Contrast Media Chemistry at the Massachusetts General Hospital; Associate Professor at Harvard Medical School
Julien Epps, PhD
Associate Professor in Signal Processing with the School of Electrical Engineering and Telecommunications at UNSW Australia
Julien Epps, PhD
Associate Professor in Signal Processing with the School of Electrical Engineering and Telecommunications at UNSW Australia
Maurizio Fava, MD
Executive Vice Chair of the Department of Psychiatry; Executive Director of the Massachusetts General Hospital Clinical Trials Network & Institute
Maurizio Fava, MD
Executive Vice Chair of the Department of Psychiatry; Executive Director of the Massachusetts General Hospital Clinical Trials Network & Institute
B. Brett Finlay, PhD
Howard Hughes Medical Institute Investigator; Professor at the University of British Columbia
B. Brett Finlay, PhD
Howard Hughes Medical Institute Investigator; Professor at the University of British Columbia
Ken Fujioka, MD
Director of the Nutrition and Metabolic Research Center and the Center for Weight Management in La Jolla California at the Scripps Clinic
Ken Fujioka, MD
Director of the Nutrition and Metabolic Research Center and the Center for Weight Management in La Jolla California at the Scripps Clinic
Adam Gazzaley, MD, PhD
Founding Director of the Neuroscience Imaging Center at the University of California, San Francisco
Adam Gazzaley, MD, PhD
Founding Director of the Neuroscience Imaging Center at the University of California, San Francisco
Allan Geliebter, PhD
Attending Psychologist at St. Luke’s-Roosevelt Hospital
Allan Geliebter, PhD
Attending Psychologist at St. Luke’s-Roosevelt Hospital
James O. Hill, PhD
Executive Director of the Anschutz Health and Wellness Center; Professor of Pediatrics and Medicine at the University of Colorado School of Medicine, Denver
James O. Hill, PhD
Executive Director of the Anschutz Health and Wellness Center; Professor of Pediatrics and Medicine at the University of Colorado School of Medicine, Denver
Kenya Honda, MD, PhD
Associate Professor of Immunology at the Graduate School of Medicine at the University of Tokyo
Kenya Honda, MD, PhD
Associate Professor of Immunology at the Graduate School of Medicine at the University of Tokyo
H. Robert Horvitz, PhD
David H. Koch Professor of Biology at Massachusetts Institute of Technology, Howard Hughes Medical Institute Investigator, and Neurobiologist (Neurology) at Massachusetts General Hospital
H. Robert Horvitz, PhD
David H. Koch Professor of Biology at Massachusetts Institute of Technology, Howard Hughes Medical Institute Investigator, and Neurobiologist (Neurology) at Massachusetts General Hospital
Akiko Iwasaki, PhD
Waldemar Von Zedtwitz Professor of Immunobiology and Molecular, Cellular and Developmental Biology and Professor of Molecular Cellular and Developmental Biology, Yale University; Howard Hughes Medical Institute Investigator
Akiko Iwasaki, PhD
Waldemar Von Zedtwitz Professor of Immunobiology and Molecular, Cellular and Developmental Biology and Professor of Molecular Cellular and Developmental Biology, Yale University; Howard Hughes Medical Institute Investigator
Lee M. Kaplan, MD, PhD
Associate Professor at Harvard Medical School; Director of the Metabolism & Nutrition Institute; founding Director of Massachusetts General Hospital Weight Center
Lee M. Kaplan, MD, PhD
Associate Professor at Harvard Medical School; Director of the Metabolism & Nutrition Institute; founding Director of Massachusetts General Hospital Weight Center
Dan Littman, MD, PhD
Howard Hughes Medical Institute Investigator, Professor of Molecular Immunology and Professor of Pathology and Microbiology at the NYU School of Medicine, member of the Board of Director's at Pfizer
Dan Littman, MD, PhD
Howard Hughes Medical Institute Investigator, Professor of Molecular Immunology and Professor of Pathology and Microbiology at the NYU School of Medicine, member of the Board of Director's at Pfizer
Ruslan Medzhitov, PhD
Howard Hughes Medical Institute Investigator; David W. Wallace Professor of Immunobiology at Yale University School of Medicine
Ruslan Medzhitov, PhD
Howard Hughes Medical Institute Investigator; David W. Wallace Professor of Immunobiology at Yale University School of Medicine
Siddhartha Mukherjee, MD, PhD
Assistant Professor of Medicine at Columbia University; Pulitzer Prize-winning author of Emperor of all Maladies
Siddhartha Mukherjee, MD, PhD
Assistant Professor of Medicine at Columbia University; Pulitzer Prize-winning author of Emperor of all Maladies
Atul Pande, MD
Former Senior Vice President, Head of Neuroscience, and Senior Advisor, Pharmaceutical R&D at GlaxoSmithKline
Atul Pande, MD
Former Senior Vice President, Head of Neuroscience, and Senior Advisor, Pharmaceutical R&D at GlaxoSmithKline
Christopher Porter, PhD
Director of the Monash Institute of Pharmaceutical Sciences (MIPS) at Monash University in Australia
Christopher Porter, PhD
Director of the Monash Institute of Pharmaceutical Sciences (MIPS) at Monash University in Australia
Alexander Rudensky, PhD
Howard Hughes Medical Institute Investigator, Tri-Institutional Professor at Memorial Sloan-Kettering Cancer Center, the Rockefeller University and Cornell University
Alexander Rudensky, PhD
Howard Hughes Medical Institute Investigator, Tri-Institutional Professor at Memorial Sloan-Kettering Cancer Center, the Rockefeller University and Cornell University
Maryanne Senna, MD
Board-Certified Dermatologist at Massachusetts General Hospital and Assistant Professor of Dermatology at Harvard Medical School; Founder and Co-Director of MGH Hair Loss Clinic
Maryanne Senna, MD
Board-Certified Dermatologist at Massachusetts General Hospital and Assistant Professor of Dermatology at Harvard Medical School; Founder and Co-Director of MGH Hair Loss Clinic
Angelo Tremblay, PhD
Professor in the Department of Kinesiology at Laval University, Quebec City
Angelo Tremblay, PhD
Professor in the Department of Kinesiology at Laval University, Quebec City